Around 100 healthcare professionals descended on London for the 2018 Encephalitis Conference on December 3.

Speakers and attendees from around the world were on hand for the go-to conference for encephalitis experts, including Professor Josep Dalmau – who discovered 10 autoimmune diseases, including Anti-NMDAR Encephalitis – and Dr Susan Hills, a Medical Epidemiologist in the Division of Vector-Borne Disease at the United States Centers for Disease Control and Prevention.

They shared the stage with a host of international speakers who talked about different aspects of encephalitis from epidemiology, diagnosis and treatment to neuropsychological and social outcomes of encephalitis.

Encephalitis Conference 2018

Click on the image to see more photographs

A number of awards were also handed out at the conference, including:

Best Presentation (winners receive £200 each, a certificate and a £50 voucher from Routledge)

Raia Blum, Department of Neurology, Icahn School of Medicine at Mount Sinai Hospital in New York: Analysis of Psychosical Outcomes of Autoimmune and Infectious Encephalitis.

Amanda Tomlinson, Department of Neurology, Icahn School of Medicine at Mount Sinai Hospital in New York: Assessment of Care Transitions and Caregiver Burden in Autoimmune and Infectious Encephalitis.

Best Poster (winners receive £100 each, a certificate and a £50 voucher from Routledge)

Dr James Varley, Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford: Contactin-associated protein 2 (CASPR2) antibody mediated neurological disease is associated with a distinct human leukocyte antigen.

Dr Vera Forminykh, IHNA RAS and Bujanov Moscow City Clinical Hospital, Moscow, Russia: Cerebrospinal fluid markers of neuronal damage and neuroinflammation in patients with autoimmune encephalitis and demyelinating disorders

Excellence in Encephalitis Healthcare Award

Meanwhile, there were also awards for Excellence in Encephalitis Healthcare for Dr Sylviane Defres and Hayley Hardwick, ENCEPH-UK, Institute of Infection and Global Health, Liverpool, for their work as project leaders on the Enceph UK study.

Thank you to our sponsors